Get started
Author

Sarbajit Mukherjee

Observed names: Mukherjee, Sarbajit, S. Mukherjee
ORCID: 0000-0003-2153-3896
Observed ORCID: 0000-0003-2153-3896
OpenAlex ID: A5122775231
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update
2026 · Manish A. Shah, Erin B. Kennedy, et al. · Journal of Clinical Oncology · 15
PDF
Perioperative chemoimmunotherapy for patients with gastric or gastroesophageal junction cancer: a systematic review and meta-analysis
2026 · Reo Omori, Yu Fujiwara, et al. · JNCI Cancer Spectrum · 4
Gender representation in first and senior authorship of phase III solid-tumor trials presented at the ASCO Annual Meeting, 2015-2025.
2026 · Sarbajit Mukherjee, Azza Sarfraz, et al. · Journal of Clinical Oncology
Determinants of leadership attainment among ASCO Leadership Development Program, 2009–2025.
2026 · Sarah Marie Abraham, Azza Sarfraz, et al. · Journal of Clinical Oncology
Global mortality and disability burden of young-onset non-colorectal gastrointestinal cancers, 1990–2021.
2026 · Shree Rath, Azza Sarfraz, et al. · Journal of Clinical Oncology
PDF
PD-1 inhibitor plus VEGFR-2 inhibitor and chemotherapy versus chemotherapy alone for locally advanced gastric cancer: A systematic review and meta-analysis.
2026 · Muhammad Ansab, Shree Rath, et al. · Journal of Clinical Oncology
Efficacy and safety of antibody-drug conjugates in gastrointestinal malignancies: A systematic review and meta-analysis of phase I-III trials.
2026 · Sawyer Bawek, Azza Sarfraz, et al. · Journal of Clinical Oncology
Neoadjuvant chemokine modulation of the tumor microenvironment (TME) in resectable metastatic colorectal cancer: Results from a phase I study.
2026 · Sarbajit Mukherjee, Amer H. Zureikat, et al. · Journal of Clinical Oncology
Hospital designation and survival disparities in young-onset gastrointestinal cancer.
2026 · Mrinalini Ramesh, Sawyer Bawek, et al. · Journal of Clinical Oncology
Geographic accessibility of recruiting clinical trials for rare and common gastrointestinal malignancies in the United States.
2026 · Rahul Kumar Thakur, Xiaoyi Zhang, et al. · Journal of Clinical Oncology
Age-stratified evaluation of subsequent primary malignancy risk in patients with primary Lynch syndrome–spectrum cancers.
2026 · Vinit Singh, Yongdong Ouyang, et al. · Journal of Clinical Oncology
Multimodal risk phenotyping of early-onset colorectal cancer.
2026 · Azza Sarfraz, Zouina Sarfraz, et al. · Journal of Clinical Oncology
Abstract 914: Racial disparities in immune-related adverse events with immune checkpoint inhibitors: A systematic review and meta-analysis.
2026 · Toshiaki Takahashi, Yu Fujiwara, et al. · Cancer Research
Efficacy, disease stabilization, and toxicity outcomes of immune checkpoint inhibitors in gastroenteropancreatic neuroendocrine tumors: A meta-analysis.
2026 · Azza Sarfraz, Zouina Sarfraz, et al. · Journal of Clinical Oncology
PDF
Metastatic patterns and outcomes among early-onset versus average-onset gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Insights from a multicenter database analysis.
2026 · Deevyashali Parekh, Suriya Baskar, et al. · Journal of Clinical Oncology
PDF
Coupling tumor genomics, whole transcriptome sequencing, and patient outcomes to define the tumor microenvironment in receptor tyrosine amplified gastrointestinal cancers: Analysis from 24,598 cases.
2026 · Kennedy Ng, Matthew Strickland, et al. · Journal of Clinical Oncology
PDF
Obesity-associated colorectal cancer and the association with chemokine signaling and tumor remodeling pathways.
2026 · Yu Fujiwara, Jianmin Wang, et al. · Journal of Clinical Oncology
ISDE guidelines on the management of cT2N0 esophageal cancer
2026 · Mukherjee, Sarbajit · Scholarly Commons - Baptist Health South Florida (Baptist Health South Florida)
455P Effects of neighborhood deprivation index on survival in upper gastrointestinal cancers
2025 · S. Mukherjee, S. Bawek, et al. · Annals of Oncology
PDF
87P Socio-demographic disparities in esophageal cancer: A SEER analysis
2022 · B. Siromoni, Y.R. Vedire, et al. · Annals of Oncology
Works count: 20
Citation count: 19
H-index: 2
I10-index: 1
Year
Topic
Type